Pathophysiology of Ganglioside GM1 in Ischemic Stroke: Ganglioside GM1: A Critical Review
Ganglioside GM1 is a member of the ganglioside family which has been used in many countries and is thought of as a promising alternative treatment for preventing several neurological diseases, including cerebral ischemic injury. The therapeutic effects of GM1 have been proved both in neonates and in...
Main Authors: | Wenchao Zhang, Paul R. Krafft, Tianlong Wang, John H. Zhang, Li Li, Jiping Tang |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-06-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.1177/0963689718822782 |
Similar Items
-
GM1 and GM2 gangliosides: recent developments
by: Bisel Blaine, et al.
Published: (2014-03-01) -
Protection against Experimental Stroke by Ganglioside GM1 Is Associated with the Inhibition of Autophagy.
by: Li Li, et al.
Published: (2016-01-01) -
Enzymatic studies on GM1 ganglioside biosynthesis
by: Rabinowitz-Kaplan, Fëıge.
Published: (1981) -
GM1 ganglioside-independent intoxication by Cholera toxin.
by: Jakob Cervin, et al.
Published: (2018-02-01) -
The interaction of GM1 ganglioside with cholera toxin on membranes of cells
by: Fletcher, Marianne Elizabeth
Published: (1991)